MS-DRGMedical
839
CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC
MS-DRG 839 groups Medicare inpatient hospital stays for: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC. This is a medical MS-DRG. It falls under MDC 17 (Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms).
Payment & Classification Data
Official CMS values from the current fiscal year's IPPS Final Rule.
| Major Diagnostic Category | MDC 17 — Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms |
| DRG Type | Medical |
| Severity Level | None |
| Relative Weight | 1.4439 |
| Relative Weight (10% Cap Applied) | 1.4439 |
| Geometric Mean Length of Stay | 4 days |
| Arithmetic Mean Length of Stay | 4.5 days |
| Post-Acute Transfer DRG | No |
| Special Pay Transfer DRG | No |